PAA 2.94% 16.5¢ pharmaust limited

Ann: Clinical Trial Report Following Phase I Trial, page-38

  1. 431 Posts.
    Hey guys,

    Extremely happy with the phase I results. Like others mentioned - the only negative being palatability.

    So every pip turns into a 2c difference post-consolidation - news released before consolidation will have a much bigger impact (SP wise). Would love to see another positive update pre-consolidation.

    Can't believe the slow uptake after Phase I results, though.

    Cheers
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
16.5¢
Change
-0.005(2.94%)
Mkt cap ! $80.25M
Open High Low Value Volume
17.0¢ 17.0¢ 16.5¢ $70.28K 418.6K

Buyers (Bids)

No. Vol. Price($)
5 217323 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 43978 1
View Market Depth
Last trade - 16.10pm 18/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.